Yonsei University: Liver Cirrhosis trials

The registry lists 13 Liver Cirrhosis studies with Yonsei University as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of the Intestinal Microbiome in Patients with CirrhosisNot yet recruitingNCT06808698
• Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver TransplantationRecruitingNCT06767579
• Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated CirrhosisStatus unknownNCT04828512
• Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesStatus unknownNCT04584242Phase 4
• Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable
• The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled TrialCompletedNCT03864276Not applicable
• Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]Status unknownNCT02514434Not applicable
• Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous DiabetesStatus unknownNCT02325622
• Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic HepatitisStatus unknownNCT01981421
• Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic PatientsStatus unknownNCT01897051Phase 2/3
• The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver CirrhosisStatus unknownNCT01741090Phase 2
• Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse ElastographyCompletedNCT01283230
• Effect of Candesartan in Alcoholic Liver FibrosisCompletedNCT00990639Phase 1/2